XNCR = 27.13 US dollar
+0.71 USD (+2.62%)
change of stock price since yesterday
Stock quotation of Xencor, Inc. in US dollar at the last deal. Stock price from verified sources. Updated stock quotes. 1 stock of Xencor, Inc. rises by 0.71 US dollar. Stock price of Xencor, Inc. goes up. The Xencor, Inc. stock price increased in US dollar by 269 hundredths of a percentage point.
Show:
to
Xencor, Inc. share price in US dollar
A month ago, Xencor, Inc. stock can be exchanged for 0 US dollar. Three months ago, Xencor, Inc. stock could be sold for 0 US dollar. Six months ago, Xencor, Inc. stock can be exchanged for 0 US dollar. Here is shown a chart of the stock price for different times. 2.57% - change in the stock price of Xencor, Inc. in US dollar per week. The change of the stock price of Xencor, Inc. in US dollar for a month is 0%.
If you have 271.30 US dollar, then in the British Virgin Islands you can purchase 10 stocks of Xencor, Inc.. Today 25 stocks of XNCR = 678.25 USD. Today, 50 stocks of Xencor, Inc. can be sold for 1 356.50 US dollar. Stock quote converter today for 100 stocks of Xencor, Inc. gives 2 713 US dollar. You can sell 250 stocks of Xencor, Inc. for 6 782.50 US dollar. You can sell 500 stocks of Xencor, Inc. for 13 565 US dollar.
XNCR stock price history
Date
Rate
Change
03/05/2023
27.13 USD
0.71 ↑
02/05/2023
26.42 USD
-0.65 ↓
01/05/2023
27.07 USD
0.63 ↑
28/04/2023
26.44 USD
-0.01 ↓
27/04/2023
26.45 USD
-
Today at 3 May 2023, 1 stock of Xencor, Inc. costs 27.13 US dollar. 2 May 2023, 1 stock of Xencor, Inc. costs 26.42 US dollar. Xencor, Inc. stock price in US dollar on 1 May 2023 - 27.07 US dollar. The maximum stock price of XNCR/USD in was on 03/05/2023. 27 April 2023, 1 stock of Xencor, Inc. = 26.45 US dollar.
Xencor, Inc.
Today's stock price of Xencor, Inc. is 27.13 $. XNCR stock price changed by +2.62% or +0.71 USD since last trading day. You can buy 100 XNCR stocks for 2 713 US dollar or sell 50 XNCR stocks for 1 356.50 US dollar.
Xencor Inc is engaged in the field of biotechnology. The United States-based firm develops drugs to combat severe diseases such as allergies and cancers.
